why choose us

First received: October 31, 2022

Clinical Trial: Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Homozygous Familial Hypercholesterolemia

Study Type: INTERVENTIONAL


Official Title: Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia in a Real Life Setting in Canada

Brief Summary: This is an open-label study designed to evaluate the long-term safety and efficacy of evinacumab, a fully human ANGPTL3 antibody, in patients with homozygous familial hypercholesterolemia (HoFH), in a real-life setting in Canada.Eligible patients for this study are male and female adult patients with HoFH.Evinacumab will be added on top of the patient's background lipid-modifying therapy (LMT), including statins, ezetimibe, PCSK9 inhibitors, lomitapide or other lipid lowering therapies.This study will be…

Read more